Skip to content
Peptigraph home

Tirzepatide for Depression: What the Evidence Shows

What human and animal studies show about Tirzepatide for depression, how strong that evidence is, and what is still unproven.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureGLP-1 / GIP dual agonistUpdated
Strongest evidence
Human RCT
Human studies
35
PubMed records, our ledger
Animal studies
2
PubMed records, our ledger
Studies we summarised
1
with an outcome for depression

Evidence for depression

Each row is an outcome related to depression from a published study, strongest design first. Animal and cell results are labelled and are not human results. User reports are not counted as evidence here.

Tirzepatide for depression: outcomes in published studies
OutcomeResultStudy typeSource
Depressive symptoms (PHQ-9)Fewer tirzepatide participants shifted to a more severe depressive-symptom category (18.2% vs 24.3% with placebo).Human RCTn = 4056Obesity 2026, PMID 41537305
Suicidal ideationSuicidal ideation was reported by 0.6% of participants in each group.Human RCTn = 4056Obesity 2026, PMID 41537305

PubMed records for Tirzepatide and depression: 35 human, 2 animal (search counts, not studies we reviewed). Grades follow our evidence scale.

How strong is it?

Strongest evidence:Human RCT evidence, 4 of 4Obesity 2026, PMID 41537305

A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.

Other peptides people research for depression

SemaglutideSelank
All peptides for depression, compared

Common questions

Does Tirzepatide help with depression?

The strongest study we summarise for depression is human rct evidence, across 1 study with an outcome for depression. A trial result is not an approval; see the legal status.

Is Tirzepatide approved for depression?

Tirzepatide is FDA approved (Mounjaro, Zepbound). Which conditions that approval covers is set by the label; use for anything else is off-label.

What is the best peptide for depression?

There is no single answer. Our depression overview compares each candidate by evidence grade and legal status rather than by popularity.

More on Tirzepatide

DosageDoses used in published studies, with the source for each.CalculatorVial, water and dose to syringe units.Side effectsWhat labels and studies report, and what is unknown.ResultsStudy outcomes and when they were measured.PricePrice per mg and per week from dated listings. No vendor links.Legal statusFDA, compounding and WADA status with dates.

Sources

  1. 1Psychiatric Safety of Tirzepatide in People With Obesity and No Known Major Psychopathology: A Post Hoc Analysis of SURMOUNT.Obesity (Silver Spring, Md.) · 2026PMID 41537305Accessed 2 Oct 2026

Found an error? Report a correction.